Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
200-559-2
Name of the chemical
Lactose C12H22O11
Concentration
N/A
General Information
Revision date
2006-12-15
Product name
Co-Betaloc
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance:
Signal word
WARNING
Hazard statements
Antihypertensive drug: has blood pressure-lowering properties Suspected of damaging the unborn child.
Additional information
Short Term: Not acutely toxic (based on components) . Known Clinical Effects: The most common adverse effects seen during clinical use of this drug include headache, chest pain, dizziness, gastrointestinal disturbances, and decreased heart rate (bradycardia). Due to intended use, dangerous lowering of blood pressure can occur. EU Indication of danger: Toxic to Reproduction; Category 3 EU Hazard Symbols: EU Risk Phrases: R63 - Possible risk of harm to the unborn child. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
